Granberg et al. performed immunostaining for FGFR3 in 676 gliomas, of which 85% were completely unstained, 10% showed weak, 3.1% showed moderate, and 1.8% showed strong staining for FGFR3 [85]. The gene discussed is FGFR3; the disease is central nervous system cancer.